INTEGRA LIFESCIENCES HOLDINGS CORP Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for the quarter ending 2011-12-31 was $14.45M.
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for the quarter ending 2011-09-30 was $12.00M.
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for the quarter ending 2011-06-30 was $52.69M.
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for the quarter ending 2011-03-31 was $4.32M.
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for fiscal 2012 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP treasury stock, value, acquired, cost method for fiscal 2010 was $31.28M.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-02-26 | |
| 2011-12-31 | $14.45M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $83.46M 8-K · filed 2014-06-20 |
| 2011-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | |
| 2011-06-30 | $52.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | |
| 2011-03-31 | $4.32M 10-Q · filed 2012-04-26 | |
| 2010-12-31 | $31.28M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |